The annual report of investment activity and ecosystem growth in Philadelphia’s startup and venture capital ecosystem noted several Penn spinouts:
- Vetigenics, co-founded by Nicola Mason, BVetMed, PhD, Professor of Medicine and Pathobiology at Penn Vet and Don Siegel, MD, PhD, Professor, Pathology & Laboratory Medicine at Penn Medicine
- Interius BioTherapeutics, co-founded by Saar Gill, MD, PhD, Associate Professor at Penn Medicine, which was acquired by Kite, a Gilead Company
- Vittoria Biotherapeutics, co-founded by Marco Ruella, MD, Associate Professor of Medicine in the Division of Hematology and Oncology at Penn Medicine.
Access the report here.